Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells

Biochemistry and Cell Biology

Volumn 86, Issue 6, 2008, Pages 477-486

  Oszajca, Katarzyna ^a   Bieniasz, Magdalena ^a   Brown, George ^a   Swiatkowska, Maria ^a   Bartkowiak, Jacek ^a   Szemraj, Janusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hydrogen peroxide; Plasminogen activator inhibitor type 1; Plasminogen activators; Sodium nitroprusside; Urokinase receptor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDES; DNA BINDINGS; EXPRESSION LEVELS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1; PLASMINOGEN ACTIVATORS; PROMOTER ACTIVITIES; PROTEIN LEVELS; SIGNALING MECHANISMS; SODIUM NITROPRUSSIDE; STRONG CORRELATIONS; UROKINASE RECEPTOR;

BLOOD VESSEL PROSTHESES; GENES; HYDROGEN; HYDROGEN PEROXIDE; MOS CAPACITORS; NITRIC OXIDE; NUCLEIC ACIDS; OLIGONUCLEOTIDES; ORGANIC ACIDS; OXIDATION; OXIDATIVE STRESS; SELF ASSEMBLY; SODIUM; SYNTHESIS (CHEMICAL);

ENDOTHELIAL CELLS;

HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITROPRUSSIDE SODIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR AP 1; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; HUMAN CELL; MOLECULAR CLONING; OXIDATIVE STRESS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; UMBILICAL VEIN;

CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXIDANTS; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR AP-1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 57749103992     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O08-137     Document Type: Article

References (57)

1. Aboul-Fadl, T. 2005. Antisense oligonucleotides: the state of the art. Curr. Med. Chem. 12(19): 2193-2214. doi:10.2174/0929867054864859. PMID:16178780.
2. Alfano, D., Franco, P., Vocca, I., Gambi, N., Pisa, V., Mancini, A., et al. 2005. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb. Haemost. 93(2): 205-211 . doi:10.1160/TH04-09-0592. PMID:15711734.
3. Binder, B.R., Mihaly, J., and Prager, G.W. 2007. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb. Haemost. 97(3): 336-342. doi:10.1160/TH06-11-0669. PMID: 17334498.
4. Blasi, F., and Carmeliet, P. 2002. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3(12): 932-943. doi:10.1038/nrm977. PMID:12461559.
5. Bonello, S., Zähringer, C., BelAiba, R.S., Djordjevic, T., Hess, J., Michiels, C., et al. 2007. Reactive oxygen species activate the HIF-1a promoter via a functional NF-kB site. Arterioscler. Thromb. Vasc. Biol. 27(4): 755-761. doi:10.1161/01.ATV. 0000258979.92828.bc. PMID:17272744.
6. Bouchie, J.L., Hansen, H., and Feener, E.P. 1998. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 18(11): 1771-1779. PMID:9812917.
7. Brown, N.J., Gainer, J.V., Stein, C.M., and Vaughan, D.E. 1999. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension, 33(6): 1431-1435. PMID:10373228.
8. Brown, N.J., Gainer, J.V., Murphey, L.J., and Vaughan, D.E. 2000. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation, 102(18): 2190-2196. PMID:11056091.
9. Castellino, F.J., and Ploplis, V.A. 2005. Structure and function of the plasminogen/plasmin system. Thromb. Haemost. 93(4): 647-654. doi:10.1160/TH04-12-0842. PMID:15841308.
10. Chapman, H.A. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9(5): 714-724. doi:10.1016/S0955-0674(97)80126-3. PMID:9330876.
11. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate - phenol - chloroform extraction. Anal. Biochem. 162(1): 156-159. doi:10.1016/0003-2697(87)90021-2. PMID:2440339.
12. de Bock, C.E., and Wang, Y. 2004. Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer. Med. Res. Rev. 24(1): 13-39. doi:10.1002/med.10054. PMID:14595671.
13. Dobrovolsky, A.B., and Titaeva, E.V. 2002. The fibrinolysis system: Regulation of activity and physiologic functions of its main components. Biochemistry (Mosc.), 67(1): 99-108. doi:10.1023/A:1013960416302. PMID:11841345.
14. Eberhardt, W., Beck, K.F., and Pfeilschifter, J. 2002. Cytokine-induced expression of tPA is differentially modulated by NO and ROS in rat mesangial cells. Kidney Int. 61(1): 20-30. doi:10.1046/j.1523-1755.2002.00087.x. PMID:11786081.
15. El-Remessy, A.B., Behzadian, M.A., Abou-Mohamed, G., Franklin, T., Caldwell, R.W., and Caldwell, R.B. 2003. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 162(6): 1995-2004. PMID:12759255.
16. Feng, Y.H., and Hart, G. 1995. In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions. Cardiovasc. Res. 30(2): 255-261. PMID:7585813.
17. Freshney, R.I. 1987. Culture of animal cells: a manual of basic technique. Alan R. Liss, Inc., New York.
18. Fujioka, S., Niu, J., Schmidt, C., Sclabas, G.M., Peng, B., Uwagawa, T., et al. 2004. NF-κB and AP-1 connection: mechanism of NF-κB-dependent regulation of AP-1 activity. Mol. Cell. Biol. 24(17): 7806-7819. doi:10.1128/MCB.24.17.7806-7819.2004. PMID:15314185.
19. Giannarelli, C., De Negri, F., Virdis, A., Ghiadoni, L., Cipriano, A., Magagna, A., et al. 2007. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. Hypertension, 49(4): 878-884. doi:10.1161/01.HYP.0000260471.16113.d8. PMID:17339540.
20. Görlach, A., Berchner-Pfannschmidt, U., Wotzlaw, C., Cool, R.H., Fandrey, J., Acker, H., et al. 2003. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1. Thromb. Haemost. 89(5): 926-935. PMID:12719791.
21. Kim, M.H., Cho, H.S., Jung, M., Jung, M., Hong, M.H., Lee, S.K., et al. 2005. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int. J. Oncol. 26(6): 1669-1674. PMID:15870884.
22. Kim, M.H., Yoo, H.S., Kim, M.Y., Baek, M.K., Kim, H.R., Kim, K.K., et al. 2007. Helicobacter pylori stimulates urokinase plasminogen activator receptor expression and cell invasiveness through reactive oxygen species and NF-κB signaling in human gastric carcinoma cells. Int. J. Mol. Med. 19(4): 689-697. PMID:17334646.
23. Kimura, H., and Esumi, H. 2003. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim. Pol. 50(1): 49-59. PMID:12673346.
24. Kohler, H.P., and Grant, P.J. 2000. Mechanisms of disease: plasminogen-activator inhibitor type 1 and coronary artery disease. N. Engl. J. Med. 342(24): 1792-1801. doi:10.1056/NEJM20000 6153422406. PMID:10853003.
25. Korn, S.H., Wouters, E.F.M., Vos, N., and Janssen-Heininger, Y.M.W. 2001. Cytokine-induced activation of nuclear factor-κB is inhibited by hydrogen peroxide through oxidative inactivation of IκB kinase. J. Biol. Chem. 276(38): 35693-35700. doi:10.1074/jbc.M104321200. PMID:11479295.
26. Kugiyama, K., Sakamoto, T., Misumi, I., Sugiyama, S., Ohgushi, M., Ogawa, H., et al. 1993. Transferable lipids in oxidized lowdensity lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ. Res. 73(2): 335-343. PMID:8330376.
27. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259): 680-685. doi:10.1038/227680a0. PMID:5432063.
28. Li, W.Y., Chong, S.S., Huang, E.Y., and Tuan, T.L. 2003. Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen. 11(4): 239-247. doi:10.1046/j.1524-475X.2003.11402.x. PMID:12846910.
29. Lijnen, H.R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. J. Thromb. Haemost. 3(1): 35-45. doi:10.1111/j.1538-7836. 2004.00827.x. PMID:15634264.
30. 2) on catabolic and anabolic gene expression in juvenile bovine chondrocytes. Osteoarthritis Cartilage, 13(10): 915-924. doi:10.1016/j.joca.2005.03.009. PMID:15950497.
31. Mateo, J., Garcia-Lecea, M., Cadenas, S., Hernandez, C., and Monada, S. 2003. Regulation of hypoxia-inducible factor-1α by nitric oxide through mitochondria-dependent and -independent pathways. Biochem. J. 376(Pt 2): 537-544. doi:10.1042/BJ20031155. PMID:14531732.
32. Mendes, A.F., Carvalho, A.P., Caramona, M.M., and Lopes, M.C. 2002. Role of nitric oxide in the activation of NF-κB, AP-1, and NOS II expression in articular chondrocytes. Inflamm. Res. 51(7): 369-375. doi:10.1007/PL00000317. PMID:12146729.
33. Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., and Brüne, B. 2003. Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases. Mol. Biol. Cell, 14(8): 3470-3481. doi:10.1091/mbc.E02-12-0791. PMID:12925778.
34. Nagamine, Y., Medcalf, R.L., and Muñoz-Cánoves, P. 2005. Transcriptional and posttranscriptional regulation of the plasminogen activator system. Thromb. Haemost. 93(4): 661-675. doi:10.1160/TH04-12-0814. PMID:15841310.
35. Newby, D.E., Wright, R.A., Dawson, P., Ludlam, C.A., Boon, N.A., Fox, K.A., and Webb, D.J. 1998. The L-arginine /nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc. Res. 38(2): 485-492. doi:10.1016/S0008-6363(98)00017-0. PMID:9709410.
36. Nikitovic, D., Holmgren, A., and Spyrou, G. 1998. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 242(1): 109-112. doi:10.1006/bbrc.1997. 7930. PMID:9439619.
37. Ogasawara, A., Arakawa, T., Kanada, T., Takuma, T., Sato, T., Kaneko, H., et al. 2001. Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP β, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 276(10): 7048-7054. doi:10.1074/jbc.M008070200. PMID:11092885.
38. Okada, H., Woodcock-Mitchell, J., Mitchell, J., Sakamoto, T., Marutsuka, K., Sobel, B.E., and Fujii, S. 1998. Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals. Circulation, 97(21): 2175-2182. PMID:9626179.
39. Pannocchia, A., Garis, G., Giorgianni, A., Stella, S., Bosia, A., and Ghigo, D. 1996. Nitroprusside has no effect on t-PA and PAI production and release by endothelial cells in culture. Fibrinolysis, 10(2): 111-115. doi:10.1016/S0268-9499(96)80086-5.
40. Pawlowska, Z., Pluskota, E., Chabielska, E., Buczko, W., Okruszek, A., Stec, W., and Cierniewski, C.S. 1998. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats. Thromb. Haemost. 79(2): 348-353. PMID:9493589.
41. Peréz-Ruiz, A., Montes, R., Velasco, F., López-Pedrera, C., Páramo, J.A., Orbe, J., et al. 2002. Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells. Thromb. Haemost. 88(6): 1060-1065. PMID:12529760.
42. Plekhanova, O., Parfyonova, Y., Bibilashvily, R., Domogatskii, S., Stepanova, V., Gulba, D.C., et al. 2001. Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms. Atherosclerosis, 159(2): 297-306. doi:10.1016/S0021-9150(01)00511-1. PMID:11730809.
43. Reynaert, N.L., Ckless, K., Korn, S.H., Vos, N., Guala, A.S., Wouters, E.F.M., et al. 2004. Nitric oxide represses inhibitory κB kinase through S-nitrosylation. Proc. Natl. Acad. Sci. U.S.A. 101(24):8945-8950. doi:10.1073/pnas.0400588101. PMID:15184672.
44. Sandau, K.B., Fandrey, J., and Brüne, B. 2001. Accumulation of HIF-1α under the influence of nitric oxide. Blood, 97(4): 1009-1015. doi:10.1182/blood.V97.4.1009. PMID:11159530.
45. Sanger, F., Nicklen, S., and Coulson, A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74(12): 5463-5467. doi:10.1073/pnas.74.12.5463. PMID:271968.
46. Simon, M.C. 2006. Mitochondrial reactive oxygen species are required for hypoxic HIFa stabilization. Adv. Exp. Med. Biol. 588:165-170. doi:10.1007/978-0-387-34817-9_15. PMID:17089888.
47. Smith, D.T., Hoetzer, G.L., Greiner, J.J., Stauffer, B.L., and DeSouza, C.A. 2003. Endothelial release of tissue-type plasminogen activator in the human forearm: role of nitric oxide. J. Cardiovasc. Pharmacol. 42(2): 311-314. doi:10.1097/00005344-200308000-00022. PMID:12883337.
48. Stein, C.M., Brown, N., Vaughan, D.E., Lang, C.C., and Wood, A.J. 1998. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J. Am. Coll. Cardiol. 32(1): 117-122. doi:10.1016/S0735-1097(98)00210-1. PMID:9669258.
49. Stepanova, V., Mukhina, S., Kohler, E., Resink, T.J., Erne, P., and Tkachuk, V.A. 1999. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol. Cell. Biochem. 195(1-2):199-206. doi:10.1023/A:1006936623106. PMID:10395084.
50. Swiatkowska, M., Cierniewska-Cieslak, A., Pawlowska, Z., and Cierniewski, C.S. 2000. Dual regulatory effects of nitric oxide on plasminogen activator inhibitor type 1 expression in endothelial cells. Eur. J. Biochem. 267(4): 1001-1007. doi:10.1046/j.1432-1327.2000.01086.x. PMID:10672008.
51. Swiatkowska, M., Szemraj, J., Al-Nedawi, K.N.I., and Pawlowska, Z. 2002. Reactive oxygen species upregulate expression of PAI-1 in endothelial cells. Cell. Mol. Biol. Lett. 7(4): 1065-1071. PMID:12511973.
52. Swiatkowska, M., Szemraj, J., and Cierniewski, C.S. 2005. Induction of PAI-1 expression by tumor necrosis factor a in endothelial cells is mediated by its responsive element located in the 4G/5G site. FEBS J. 272(22): 5821-5831. doi:10.1111/j.1742-4658.2005.04979.x. PMID:16279946.
53. Takada, Y., Mukhopadhyay, A., Kundu, G.C., Mahabeleshwar, G.H., Singh, S., and Aggarwal, B.B. 2003. Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65. J. Biol. Chem. 278(26): 24233-24241. doi:10.1074/jbc.M212389200. PMID:12711606.
54. Umansky, V., Hehner, S.P., Dumont, A., Hofmann, T.G., Schirrmacher, V., Dröge, W., and Schmitz, M.L. 1998. Co-stimulatory effect of nitric oxide on endothelial NF-κB implies a physiological self-amplifying mechanizm. Eur. J. Immunol. 28(8): 2276-2282. doi:10.1002/(SICI)1521-4141(199808)28: 08〈2276::AID-IMMU2276〉3.0.CO;2-H. PMID:9710205.
55. Watanabe, Y., Takahashi, H., Uno, S., Takano, S., and Nakagawa, S. 2003. Expression of type 1 plasminogen activator inhibitor and nitric oxide generation in ischemic preconditioning of rat liver. Hepatol. Res. 25(3): 343-353. doi:10.1016/S1386-6346(02)00305-4. PMID:12697256.
56. Winer, J., Jung, C.K.S., Shackel, I., and Williams, P.M. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270(1): 41-49. doi:10.1006/abio.1999.4085. PMID:10328763.
57. Ziche, M., Parenti, A., Ledda, F., Dell'Era, P., Granger, H.J., Maggi, C.A., and Presta, M. 1997. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res. 80(6): 845-852. PMID:9168787.